3421 related articles for article (PubMed ID: 18498797)
21. Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution.
Malaisrie SC; Untch B; Aranha GV; Mohideen N; Hantel A; Pickleman J
Arch Surg; 2004 May; 139(5):532-8; discussion 538-9. PubMed ID: 15136354
[TBL] [Abstract][Full Text] [Related]
22. Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer.
Sujendran V; Wheeler J; Baron R; Warren BF; Maynard N
Br J Surg; 2008 Feb; 95(2):191-4. PubMed ID: 17948302
[TBL] [Abstract][Full Text] [Related]
23. Weekly chemotherapy with cisplatin and paclitaxel and concurrent radiation therapy as preoperative treatment in locally advanced esophageal cancer: a phase II study.
Orditura M; Galizia G; Napolitano V; Martinelli E; Pacelli R; Lieto E; Aurilio G; Vecchione L; Morgillo F; Catalano G; Ciardiello F; Del Genio A; Di Martino N; De Vita F
Cancer Invest; 2010 Oct; 28(8):820-7. PubMed ID: 20482249
[TBL] [Abstract][Full Text] [Related]
24. Management for patients with advanced T4 epidermoid carcinoma of the esophagus.
Wang LS; Chi KH; Hu MH; Fahn HJ; Huang MH
J Surg Oncol; 1996 May; 62(1):22-9. PubMed ID: 8618396
[TBL] [Abstract][Full Text] [Related]
25. Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study.
Hsu FM; Lin CC; Lee JM; Chang YL; Hsu CH; Tsai YC; Lee YC; Cheng JC
J Surg Oncol; 2008 Jul; 98(1):34-41. PubMed ID: 18449912
[TBL] [Abstract][Full Text] [Related]
26. Downstaging of T or N predicts long-term survival after preoperative chemotherapy and radical resection for esophageal carcinoma.
Korst RJ; Kansler AL; Port JL; Lee PC; Kerem Y; Altorki NK
Ann Thorac Surg; 2006 Aug; 82(2):480-4; discussion 484-5. PubMed ID: 16863749
[TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant, surgery and adjuvant chemotherapy without radiation for esophageal cancer.
Ardalan B; Spector SA; Livingstone AS; Franceschi D; Mezentsev D; Lima M; Bowen-Wells CP; Sparling L; Avisar E; Sapp M; Rios J; Walker G; Ganjei-Azar P
Jpn J Clin Oncol; 2007 Aug; 37(8):590-6. PubMed ID: 17704532
[TBL] [Abstract][Full Text] [Related]
28. Erythropoietin-alfa during neoadjuvant chemotherapy for locally advanced esophagogastric adenocarcinoma.
Abbrederis K; Bassermann F; Schuhmacher C; Voelter V; Busch R; Roethling N; Sendler A; Siewert JR; Peschel C; Lordick F
Ann Thorac Surg; 2006 Jul; 82(1):293-7. PubMed ID: 16798232
[TBL] [Abstract][Full Text] [Related]
29. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD
J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330
[TBL] [Abstract][Full Text] [Related]
30. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus.
Heath EI; Burtness BA; Heitmiller RF; Salem R; Kleinberg L; Knisely JP; Yang SC; Talamini MA; Kaufman HS; Canto MI; Topazian M; Wu TT; Olukayode K; Forastiere AA
J Clin Oncol; 2000 Feb; 18(4):868-76. PubMed ID: 10673530
[TBL] [Abstract][Full Text] [Related]
31. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial.
Meluch AA; Hainsworth JD; Gray JR; Thomas M; Whitworth PL; Davis JL; Greco FA
Cancer J Sci Am; 1999; 5(2):84-91. PubMed ID: 10198730
[TBL] [Abstract][Full Text] [Related]
32. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H
J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937
[TBL] [Abstract][Full Text] [Related]
33. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer.
Kelsen DP; Ginsberg R; Pajak TF; Sheahan DG; Gunderson L; Mortimer J; Estes N; Haller DG; Ajani J; Kocha W; Minsky BD; Roth JA
N Engl J Med; 1998 Dec; 339(27):1979-84. PubMed ID: 9869669
[TBL] [Abstract][Full Text] [Related]
34. Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease.
Stiles BM; Mirza F; Coppolino A; Port JL; Lee PC; Paul S; Altorki NK
Ann Thorac Surg; 2011 Aug; 92(2):491-6; discussion 496-8. PubMed ID: 21704291
[TBL] [Abstract][Full Text] [Related]
35. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.
Hejna M; Kornek GV; Schratter-Sehn AU; Zach M; Schoder M; Raderer M; Rosen H; Schiessel R; Scheithauer W
Cancer; 1996 Oct; 78(8):1646-50. PubMed ID: 8859175
[TBL] [Abstract][Full Text] [Related]
36. Prospective non-randomized trial comparing esophagectomy-followed-by-chemoradiotherapy versus chemoradiotherapy-followed-by-esophagectomy for T4 esophageal cancers.
Fujita H; Sueyoshi S; Tanaka T; Tanaka Y; Sasahara H; Shirouzu K; Suzuki G; Hayabuchi N; Inutsuka H
J Surg Oncol; 2005 Jun; 90(4):209-19. PubMed ID: 15906363
[TBL] [Abstract][Full Text] [Related]
37. [Neoadjuvant treatment in surgery of esophageal cancer].
Launois B; Raoul JL; Leprise E; Meunier B
Bull Acad Natl Med; 2000; 184(8):1703-13; discussion 1714. PubMed ID: 11471389
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant chemotherapy (FAP) for advanced esophageal cancer.
Shimakawa T; Naritaka Y; Asaka S; Isohata N; Murayama M; Konno S; Yoshimatsu K; Shiozawa S; Katsube T; Ogawa K
Anticancer Res; 2008; 28(4C):2321-6. PubMed ID: 18751413
[TBL] [Abstract][Full Text] [Related]
39. [Preoperative chemoradiation in esophageal cancer: experience of a single center in 102 patients].
Imdahl A; Schöffel U; Ruf G; Hopf UT
Zentralbl Chir; 2004 Oct; 129(5):350-5. PubMed ID: 15486784
[TBL] [Abstract][Full Text] [Related]
40. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]